Adachi, Hisashi

Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects

Yamagishi, S.-I., Adachi, H., Nakamura, K., Matsui, T., Jinnouchi, Y., Takenaka, K., Takeuchi, M., Enomoto, M., Furuki, K., Hino, A., et al. (2006) · Metabolism

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 148

Forty-year coronary mortality trends and changes in major risk factors in the first 10 years of follow-up in the seven countries study

Menotti, A., Lanti, M., Kromhout, D., Blackburn, H., Nissinen, A., Dontas, A., Kafatos, A., Nedeljkovic, S., & Adachi, H. (2007) · European Journal of Epidemiology

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 61

Positive association of serum levels of advanced glycation end products and high mobility group box–1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients

Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Ueda, Y., Suzuki, T., Yamada, S., Takeuchi, M., Fukami, K., Ueda, S., et al. (2009) · Metabolism

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 53

Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock

Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Suzuki, T., Ueda, Y., Yamada, S., Shoji, H., Takeuchi, M., Ueda, S., et al. (2009) · Pharmacological Research

Advanced Glycation End Products researchSepsis Diagnosis and Treatment

Cited by 46